1. I. Björk, S. T. Olson, and J. D. Shore, Molecular mechanisms of the accelerating effect of heparin on the reactions between antithrombin and clotting proteinases, in: “Heparin. Chemical and Biological Properties. Clinical Applications”, D. A. Lane and U. Lindahl, eds., Edward Arnold, London (1989).
2. S. T. Olson and I. Björk, Regulation of thrombin by antithrombin and heparin cofactor II, in: “Thrombin: Structure and function”, L. J. Berliner, ed., Plenum, New York City (1991).
3. I. Björk and W. W. Fish, Production in vitro and properties of a modified form of bovine antithrombin, cleaved at the active site by thrombin, J. Biol. Chem. 257:9487 (1982).
4. S. T. Olson, Heparin and ionic strength-dependent conversion of antithrombin III from an inhibitor to a substrate of a-thrombin, J. Biol. Chem. 260:10153 (1985).
5. H. Erdjument, D. A. Lane, M. Panico, V. DiMarzo, and H. R. Morris, Single amino acid substitutions in the reactive site of antithrombin leading to thrombosis. Congenital substitution of arginine 393 to cysteine in antithrombin Northwick Park and to histidine in antithrombin Glasgow. J. Biol. Chem. 263:5589 (1988).